Click for best price
Acute Kidney Injury Therapeutics Market Size, Share 2024
Acute kidney injury therapeutics is the cure to the acute kidney injury that is a group of clinical syndromes that refers to sudden (within 1-7d) and sustained (> 24h) sudden declines in renal function. It is defined as an increase in serum creatinine (SCr) of at least 0.5mg / dl 1 and manifested as nitrogen. Plasmaemia, water-electrolyte and acid-base balance and systemic symptoms can be accompanied by oliguria (<400ml / 24h or 17ml / h) or anuria (<100ml / 24h).
This report aims to provide a comprehensive presentation of the global market for Acute Kidney Injury Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Kidney Injury Therapeutics. This report contains market size and forecasts of Acute Kidney Injury Therapeutics in global, including the following market information:
Global Acute Kidney Injury Therapeutics Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Acute Kidney Injury Therapeutics market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Non-drug Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Acute Kidney Injury Therapeutics include Quark Pharmaceuticals, Alloksys, Angio Biomedica Corporation, Stealth Bio Therapeutics, Silver Creek Pharmaceuticals, AM Pharma Holding, Ischemix, Biomerieux and A1M Pharma, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Acute Kidney Injury Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acute Kidney Injury Therapeutics Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Acute Kidney Injury Therapeutics Market Segment Percentages, by Type, 2023 (%)
Non-drug
Drugs
Global Acute Kidney Injury Therapeutics Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Acute Kidney Injury Therapeutics Market Segment Percentages, by Application, 2023 (%)
Hospitals
Clinic
Other
Global Acute Kidney Injury Therapeutics Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Acute Kidney Injury Therapeutics Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acute Kidney Injury Therapeutics revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Acute Kidney Injury Therapeutics revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Quark Pharmaceuticals
Alloksys
Angio Biomedica Corporation
Stealth Bio Therapeutics
Silver Creek Pharmaceuticals
AM Pharma Holding
Ischemix
Biomerieux
A1M Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Acute Kidney Injury Therapeutics, market overview.
Chapter 2: Global Acute Kidney Injury Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Acute Kidney Injury Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Acute Kidney Injury Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Acute Kidney Injury Therapeutics Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Acute Kidney Injury Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acute Kidney Injury Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acute Kidney Injury Therapeutics Overall Market Size
2.1 Global Acute Kidney Injury Therapeutics Market Size: 2023 VS 2030
2.2 Global Acute Kidney Injury Therapeutics Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acute Kidney Injury Therapeutics Players in Global Market
3.2 Top Global Acute Kidney Injury Therapeutics Companies Ranked by Revenue
3.3 Global Acute Kidney Injury Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Acute Kidney Injury Therapeutics Companies in Global Market, by Revenue in 2023
3.5 Global Companies Acute Kidney Injury Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Kidney Injury Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Acute Kidney Injury Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Acute Kidney Injury Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Acute Kidney Injury Therapeutics Market Size Markets, 2023 & 2030
4.1.2 Non-drug
4.1.3 Drugs
4.2 By Type - Global Acute Kidney Injury Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Acute Kidney Injury Therapeutics Revenue, 2019-2024
4.2.2 By Type - Global Acute Kidney Injury Therapeutics Revenue, 2025-2030
4.2.3 By Type - Global Acute Kidney Injury Therapeutics Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Acute Kidney Injury Therapeutics Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global Acute Kidney Injury Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Acute Kidney Injury Therapeutics Revenue, 2019-2024
5.2.2 By Application - Global Acute Kidney Injury Therapeutics Revenue, 2025-2030
5.2.3 By Application - Global Acute Kidney Injury Therapeutics Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Acute Kidney Injury Therapeutics Market Size, 2023 & 2030
6.2 By Region - Global Acute Kidney Injury Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Acute Kidney Injury Therapeutics Revenue, 2019-2024
6.2.2 By Region - Global Acute Kidney Injury Therapeutics Revenue, 2025-2030
6.2.3 By Region - Global Acute Kidney Injury Therapeutics Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Acute Kidney Injury Therapeutics Revenue, 2019-2030
6.3.2 US Acute Kidney Injury Therapeutics Market Size, 2019-2030
6.3.3 Canada Acute Kidney Injury Therapeutics Market Size, 2019-2030
6.3.4 Mexico Acute Kidney Injury Therapeutics Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Acute Kidney Injury Therapeutics Revenue, 2019-2030
6.4.2 Germany Acute Kidney Injury Therapeutics Market Size, 2019-2030
6.4.3 France Acute Kidney Injury Therapeutics Market Size, 2019-2030
6.4.4 U.K. Acute Kidney Injury Therapeutics Market Size, 2019-2030
6.4.5 Italy Acute Kidney Injury Therapeutics Market Size, 2019-2030
6.4.6 Russia Acute Kidney Injury Therapeutics Market Size, 2019-2030
6.4.7 Nordic Countries Acute Kidney Injury Therapeutics Market Size, 2019-2030
6.4.8 Benelux Acute Kidney Injury Therapeutics Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Acute Kidney Injury Therapeutics Revenue, 2019-2030
6.5.2 China Acute Kidney Injury Therapeutics Market Size, 2019-2030
6.5.3 Japan Acute Kidney Injury Therapeutics Market Size, 2019-2030
6.5.4 South Korea Acute Kidney Injury Therapeutics Market Size, 2019-2030
6.5.5 Southeast Asia Acute Kidney Injury Therapeutics Market Size, 2019-2030
6.5.6 India Acute Kidney Injury Therapeutics Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Acute Kidney Injury Therapeutics Revenue, 2019-2030
6.6.2 Brazil Acute Kidney Injury Therapeutics Market Size, 2019-2030
6.6.3 Argentina Acute Kidney Injury Therapeutics Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Acute Kidney Injury Therapeutics Revenue, 2019-2030
6.7.2 Turkey Acute Kidney Injury Therapeutics Market Size, 2019-2030
6.7.3 Israel Acute Kidney Injury Therapeutics Market Size, 2019-2030
6.7.4 Saudi Arabia Acute Kidney Injury Therapeutics Market Size, 2019-2030
6.7.5 UAE Acute Kidney Injury Therapeutics Market Size, 2019-2030
7 Acute Kidney Injury Therapeutics Companies Profiles
7.1 Quark Pharmaceuticals
7.1.1 Quark Pharmaceuticals Company Summary
7.1.2 Quark Pharmaceuticals Business Overview
7.1.3 Quark Pharmaceuticals Acute Kidney Injury Therapeutics Major Product Offerings
7.1.4 Quark Pharmaceuticals Acute Kidney Injury Therapeutics Revenue in Global Market (2019-2024)
7.1.5 Quark Pharmaceuticals Key News & Latest Developments
7.2 Alloksys
7.2.1 Alloksys Company Summary
7.2.2 Alloksys Business Overview
7.2.3 Alloksys Acute Kidney Injury Therapeutics Major Product Offerings
7.2.4 Alloksys Acute Kidney Injury Therapeutics Revenue in Global Market (2019-2024)
7.2.5 Alloksys Key News & Latest Developments
7.3 Angio Biomedica Corporation
7.3.1 Angio Biomedica Corporation Company Summary
7.3.2 Angio Biomedica Corporation Business Overview
7.3.3 Angio Biomedica Corporation Acute Kidney Injury Therapeutics Major Product Offerings
7.3.4 Angio Biomedica Corporation Acute Kidney Injury Therapeutics Revenue in Global Market (2019-2024)
7.3.5 Angio Biomedica Corporation Key News & Latest Developments
7.4 Stealth Bio Therapeutics
7.4.1 Stealth Bio Therapeutics Company Summary
7.4.2 Stealth Bio Therapeutics Business Overview
7.4.3 Stealth Bio Therapeutics Acute Kidney Injury Therapeutics Major Product Offerings
7.4.4 Stealth Bio Therapeutics Acute Kidney Injury Therapeutics Revenue in Global Market (2019-2024)
7.4.5 Stealth Bio Therapeutics Key News & Latest Developments
7.5 Silver Creek Pharmaceuticals
7.5.1 Silver Creek Pharmaceuticals Company Summary
7.5.2 Silver Creek Pharmaceuticals Business Overview
7.5.3 Silver Creek Pharmaceuticals Acute Kidney Injury Therapeutics Major Product Offerings
7.5.4 Silver Creek Pharmaceuticals Acute Kidney Injury Therapeutics Revenue in Global Market (2019-2024)
7.5.5 Silver Creek Pharmaceuticals Key News & Latest Developments
7.6 AM Pharma Holding
7.6.1 AM Pharma Holding Company Summary
7.6.2 AM Pharma Holding Business Overview
7.6.3 AM Pharma Holding Acute Kidney Injury Therapeutics Major Product Offerings
7.6.4 AM Pharma Holding Acute Kidney Injury Therapeutics Revenue in Global Market (2019-2024)
7.6.5 AM Pharma Holding Key News & Latest Developments
7.7 Ischemix
7.7.1 Ischemix Company Summary
7.7.2 Ischemix Business Overview
7.7.3 Ischemix Acute Kidney Injury Therapeutics Major Product Offerings
7.7.4 Ischemix Acute Kidney Injury Therapeutics Revenue in Global Market (2019-2024)
7.7.5 Ischemix Key News & Latest Developments
7.8 Biomerieux
7.8.1 Biomerieux Company Summary
7.8.2 Biomerieux Business Overview
7.8.3 Biomerieux Acute Kidney Injury Therapeutics Major Product Offerings
7.8.4 Biomerieux Acute Kidney Injury Therapeutics Revenue in Global Market (2019-2024)
7.8.5 Biomerieux Key News & Latest Developments
7.9 A1M Pharma
7.9.1 A1M Pharma Company Summary
7.9.2 A1M Pharma Business Overview
7.9.3 A1M Pharma Acute Kidney Injury Therapeutics Major Product Offerings
7.9.4 A1M Pharma Acute Kidney Injury Therapeutics Revenue in Global Market (2019-2024)
7.9.5 A1M Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Acute Kidney Injury Therapeutics Market Opportunities & Trends in Global Market
Table 2. Acute Kidney Injury Therapeutics Market Drivers in Global Market
Table 3. Acute Kidney Injury Therapeutics Market Restraints in Global Market
Table 4. Key Players of Acute Kidney Injury Therapeutics in Global Market
Table 5. Top Acute Kidney Injury Therapeutics Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Acute Kidney Injury Therapeutics Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Acute Kidney Injury Therapeutics Revenue Share by Companies, 2019-2024
Table 8. Global Companies Acute Kidney Injury Therapeutics Product Type
Table 9. List of Global Tier 1 Acute Kidney Injury Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Kidney Injury Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Acute Kidney Injury Therapeutics Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Acute Kidney Injury Therapeutics Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Acute Kidney Injury Therapeutics Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Acute Kidney Injury Therapeutics Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Acute Kidney Injury Therapeutics Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Acute Kidney Injury Therapeutics Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2025-2030
Table 30. Quark Pharmaceuticals Company Summary
Table 31. Quark Pharmaceuticals Acute Kidney Injury Therapeutics Product Offerings
Table 32. Quark Pharmaceuticals Acute Kidney Injury Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 33. Quark Pharmaceuticals Key News & Latest Developments
Table 34. Alloksys Company Summary
Table 35. Alloksys Acute Kidney Injury Therapeutics Product Offerings
Table 36. Alloksys Acute Kidney Injury Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 37. Alloksys Key News & Latest Developments
Table 38. Angio Biomedica Corporation Company Summary
Table 39. Angio Biomedica Corporation Acute Kidney Injury Therapeutics Product Offerings
Table 40. Angio Biomedica Corporation Acute Kidney Injury Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 41. Angio Biomedica Corporation Key News & Latest Developments
Table 42. Stealth Bio Therapeutics Company Summary
Table 43. Stealth Bio Therapeutics Acute Kidney Injury Therapeutics Product Offerings
Table 44. Stealth Bio Therapeutics Acute Kidney Injury Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 45. Stealth Bio Therapeutics Key News & Latest Developments
Table 46. Silver Creek Pharmaceuticals Company Summary
Table 47. Silver Creek Pharmaceuticals Acute Kidney Injury Therapeutics Product Offerings
Table 48. Silver Creek Pharmaceuticals Acute Kidney Injury Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 49. Silver Creek Pharmaceuticals Key News & Latest Developments
Table 50. AM Pharma Holding Company Summary
Table 51. AM Pharma Holding Acute Kidney Injury Therapeutics Product Offerings
Table 52. AM Pharma Holding Acute Kidney Injury Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 53. AM Pharma Holding Key News & Latest Developments
Table 54. Ischemix Company Summary
Table 55. Ischemix Acute Kidney Injury Therapeutics Product Offerings
Table 56. Ischemix Acute Kidney Injury Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 57. Ischemix Key News & Latest Developments
Table 58. Biomerieux Company Summary
Table 59. Biomerieux Acute Kidney Injury Therapeutics Product Offerings
Table 60. Biomerieux Acute Kidney Injury Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 61. Biomerieux Key News & Latest Developments
Table 62. A1M Pharma Company Summary
Table 63. A1M Pharma Acute Kidney Injury Therapeutics Product Offerings
Table 64. A1M Pharma Acute Kidney Injury Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 65. A1M Pharma Key News & Latest Developments
List of Figures
Figure 1. Acute Kidney Injury Therapeutics Segment by Type in 2023
Figure 2. Acute Kidney Injury Therapeutics Segment by Application in 2023
Figure 3. Global Acute Kidney Injury Therapeutics Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Acute Kidney Injury Therapeutics Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Acute Kidney Injury Therapeutics Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Acute Kidney Injury Therapeutics Revenue in 2023
Figure 8. By Type - Global Acute Kidney Injury Therapeutics Revenue Market Share, 2019-2030
Figure 9. By Application - Global Acute Kidney Injury Therapeutics Revenue Market Share, 2019-2030
Figure 10. By Type - Global Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Acute Kidney Injury Therapeutics Revenue Market Share, 2019-2030
Figure 12. By Application - Global Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Acute Kidney Injury Therapeutics Revenue Market Share, 2019-2030
Figure 14. By Region - Global Acute Kidney Injury Therapeutics Revenue Market Share, 2019-2030
Figure 15. By Country - North America Acute Kidney Injury Therapeutics Revenue Market Share, 2019-2030
Figure 16. US Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Acute Kidney Injury Therapeutics Revenue Market Share, 2019-2030
Figure 20. Germany Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 21. France Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Acute Kidney Injury Therapeutics Revenue Market Share, 2019-2030
Figure 28. China Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 32. India Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Acute Kidney Injury Therapeutics Revenue Market Share, 2019-2030
Figure 34. Brazil Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Acute Kidney Injury Therapeutics Revenue Market Share, 2019-2030
Figure 37. Turkey Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Acute Kidney Injury Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 41. Quark Pharmaceuticals Acute Kidney Injury Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Alloksys Acute Kidney Injury Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Angio Biomedica Corporation Acute Kidney Injury Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Stealth Bio Therapeutics Acute Kidney Injury Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Silver Creek Pharmaceuticals Acute Kidney Injury Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. AM Pharma Holding Acute Kidney Injury Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Ischemix Acute Kidney Injury Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Biomerieux Acute Kidney Injury Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. A1M Pharma Acute Kidney Injury Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
